XML 221 R31.htm IDEA: XBRL DOCUMENT v3.25.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Assets and Liabilities Measured at Fair Value on Recurring Basis
The following tables present the fair value of assets and liabilities measured at fair value on a recurring basis as of September 30, 2025 and December 31, 2024 (dollars in millions):
As of September 30, 2025
Fair Value Measured and Recorded Using
Level 1Level 2Level 3Total
Assets
Available for sale debt securities:
U.S. treasury securities$$— $— $
Corporate debt securities— 35 — 35 
Asset-backed securities— — 
Total available for sale debt securities42 — 46 
Equity securities18 — — 18 
Investments in unconsolidated subsidiaries— — 24 24 
Warehouse receivables— 1,647 — 1,647 
Derivative assets— 50 — 50 
Total assets at fair value$22 $1,739 $24 $1,785 
Liabilities
Contingent consideration— — 31 31 
Derivative liabilities— 454 — 454 
Total liabilities at fair value$— $454 $31 $485 
As of December 31, 2024
Fair Value Measured and Recorded Using
Level 1Level 2Level 3Total
Assets
Available for sale debt securities:
U.S. treasury securities$$— $— $
Corporate debt securities— 33 — 33 
Asset-backed securities— — 
Total available for sale debt securities40 — 43 
Equity securities18 — — 18 
Investments in unconsolidated subsidiaries100 — 412 512 
Warehouse receivables— 561 — 561 
Derivative assets— 43 — 43 
Other assets— — 46 46 
Total assets at fair value$121 $644 $458 $1,223 
Liabilities
Contingent consideration— — 36 36 
Total liabilities at fair value$— $— $36 $36 
Schedule of Reconciliation for Assets Measured at Fair Value
The tables below present a reconciliation for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (dollars in millions):
Investment in Unconsolidated SubsidiariesOther AssetsContingent Consideration
Balance as of June 30, 2025$24 $— $27 
Transfer in (out)— — — 
Net change in fair value— — — 
Purchases / Additions— — 
Sales / Payments
— — — 
Balance as of September 30, 2025$24 $— $31 
Balance as of December 31, 2024$412 $46 $36 
Transfer in (out)(14)— (2)
Net change in fair value(1)— (7)
Purchases / Additions— — 
Sales / Payments (1)
(373)(46)— 
Balance as of September 30, 2025$24 $— $31 
________________________________________________________________________________________________________________________________________
(1)As disclosed in Note 3 – Acquisitions, on January 16, 2025, we acquired the remaining 60% ownership interest in Industrious.
Net change in fair value, included in the table above, is reported in Net income as follows:
Category of Assets/Liabilities using Unobservable Inputs
Consolidated Financial Statements
Investments in unconsolidated subsidiariesEquity income (loss) from unconsolidated subsidiaries
Other assets (liabilities)Other income
Contingent consideration (short-term)
Accounts payable and accrued expenses
Contingent consideration (long-term)
Other liabilities
Schedule of Reconciliation for Liabilities Measured at Fair Value
The tables below present a reconciliation for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (dollars in millions):
Investment in Unconsolidated SubsidiariesOther AssetsContingent Consideration
Balance as of June 30, 2025$24 $— $27 
Transfer in (out)— — — 
Net change in fair value— — — 
Purchases / Additions— — 
Sales / Payments
— — — 
Balance as of September 30, 2025$24 $— $31 
Balance as of December 31, 2024$412 $46 $36 
Transfer in (out)(14)— (2)
Net change in fair value(1)— (7)
Purchases / Additions— — 
Sales / Payments (1)
(373)(46)— 
Balance as of September 30, 2025$24 $— $31 
________________________________________________________________________________________________________________________________________
(1)As disclosed in Note 3 – Acquisitions, on January 16, 2025, we acquired the remaining 60% ownership interest in Industrious.
Net change in fair value, included in the table above, is reported in Net income as follows:
Category of Assets/Liabilities using Unobservable Inputs
Consolidated Financial Statements
Investments in unconsolidated subsidiariesEquity income (loss) from unconsolidated subsidiaries
Other assets (liabilities)Other income
Contingent consideration (short-term)
Accounts payable and accrued expenses
Contingent consideration (long-term)
Other liabilities
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments
Estimated Fair Value
Carrying Value
Financial instrument
September 30, 2025December 31, 2024September 30, 2025December 31, 2024
Senior term loans due in 2028
$1,256 $708 $1,338 $718 
5.950% senior notes due in 2034
1,069 1,033 977 976 
4.875% senior notes due in 2026
— 600 — 599 
4.800% senior notes due in 2030
610 — 590 — 
5.500% senior notes due in 2035
515 — 494 — 
5.500% senior notes due in 2029
519 509 496 496 
2.500% senior notes due in 2031
453 426 493 492